Lauren D’angelo Acquires 3,500 Shares of Alpha Cognition (NASDAQ:ACOG) Stock

Alpha Cognition Inc. (NASDAQ:ACOG) COO Lauren D’angelo acquired 3,500 shares of the business’s stock in a transaction on Tuesday, May 19th. The stock was purchased at an average cost of $5.76 per share, with a total value of $20,160.00. Following the acquisition, the chief operating officer directly owned 140,695 shares of the company’s stock, valued at $810,403.20. This represents a 2.55% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Alpha Cognition Stock Performance

ACOG opened at $5.89 on Thursday. The stock has a market capitalization of $128.23 million, a price-to-earnings ratio of -4.36 and a beta of 2.38. The company has a fifty day moving average of $6.07 and a two-hundred day moving average of $5.90. Alpha Cognition Inc. has a fifty-two week low of $4.50 and a fifty-two week high of $11.54.

Alpha Cognition (NASDAQ:ACOG) last released its earnings results on Thursday, May 14th. The company reported ($0.37) EPS for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.04. Alpha Cognition had a negative net margin of 232.23% and a negative return on equity of 58.35%. The business had revenue of $3.53 million during the quarter, compared to analysts’ expectations of $3.42 million. On average, equities research analysts forecast that Alpha Cognition Inc. will post -1.34 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently weighed in on ACOG. Craig Hallum assumed coverage on shares of Alpha Cognition in a research note on Friday, April 17th. They set a “buy” rating and a $14.00 target price on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $18.00 target price on shares of Alpha Cognition in a research report on Monday, April 27th. Finally, Wall Street Zen cut shares of Alpha Cognition from a “hold” rating to a “sell” rating in a research note on Saturday, May 2nd. Two research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $16.00.

Hedge Funds Weigh In On Alpha Cognition

Hedge funds have recently added to or reduced their stakes in the business. Green Alpha Advisors LLC purchased a new position in Alpha Cognition during the 4th quarter valued at about $72,000. Geode Capital Management LLC purchased a new stake in shares of Alpha Cognition during the second quarter worth about $112,000. Berkshire Asset Management LLC PA grew its holdings in shares of Alpha Cognition by 50.7% during the third quarter. Berkshire Asset Management LLC PA now owns 17,824 shares of the company’s stock worth $116,000 after buying an additional 6,000 shares in the last quarter. Massar Capital Management LP purchased a new stake in shares of Alpha Cognition during the second quarter worth about $116,000. Finally, Two Sigma Investments LP purchased a new stake in shares of Alpha Cognition during the third quarter worth about $148,000.

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.